Tumor mutation burden: from comprehensive mutational screening to the clinic

The recent advent of immunomodulatory therapies into the clinic has demanded the identification of innovative predictive biomarkers to identify patients most likely to respond to immunotherapy and support the design of tailored clinical trials. Current molecular testing for selection of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Galuppini, Francesca, Dal Pozzo, Carlo Alberto, Deckert, Jutta, Loupakis, Fotios, Fassan, Matteo, Baffa, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686509/
https://www.ncbi.nlm.nih.gov/pubmed/31406485
http://dx.doi.org/10.1186/s12935-019-0929-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686509/
https://www.ncbi.nlm.nih.gov/pubmed/31406485
http://dx.doi.org/10.1186/s12935-019-0929-4

Ejemplares similares